Press Releases from oncgnostics GmbH (3 total)
"GynTect 2.0"- Wider range of application by using a greater variety of patient …
Jena, September 21th, 2016 – GynTect, a molecular diagnostic test developed by the biotech company oncgnostics (www.oncgnostics.com), allows fast and reliable diagnostics of cervical cancer…
oncgnostics and Greiner Bio-One sign Partnership Agreement
Jena / Frickenhausen (Germany), November 18th, 2015 – The oncgnostics GmbH has taken on board the international firm Greiner Bio-One GmbH as a sales…
oncgnostics presents novel cervical cancer triage test GynTect® at MEDICA 2015
Jena, October 29th, 2015 – At the medical trade fair MEDICA 2015 the biotech company oncgnostics GmbH (www.oncgnostics.com) presents its new product GynTect - a…
Go To Page:
